跳至主要内容
临床试验/NCT04982341
NCT04982341已完成不适用

Effectiveness of High-flow Nasal Cannula and Prone Positioning in Awake Patients With COVID-19 and Severe Acute Respiratory Failure

Hôpital Universitaire Fattouma Bourguiba1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2020年9月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
Number of patients without intubation

研究概览

简要总结

The investigators evaluate the effects of High-flow nasal cannula (HFNC) in association with prone in patients with Covid-19 severe ARF.

详细描述

The investigators evaluate the effects of High-flow nasal cannula (HFNC) in association with prone in patients with Covid-19 severe ARF.

All patients with ARF related to Covid-19 and admitted to the ICU are turned in prone position whenever tolerated, while receiving oxygenation with HFNC.

Outcomes of interest are the rate of success or failure (defined as the need for intubation and mechanical ventilation)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • aged ≥18 years, admitted to the medical ICU for confirmed Covid-19 and acute hypoxemic respiratory failure

排除标准

  • patients already intubated at admission or those requiring immediate intubation

结局指标

主要结局

Number of patients without intubation

时间窗: through study completion, an average of 28 days

successful oxygenation without intubation

次要结局

未报告次要终点

研究者

发起方
Hôpital Universitaire Fattouma Bourguiba
申办方类型
Other
责任方
Principal Investigator
主要研究者

Fekri Abroug

Professor Head of the ICU

Hôpital Universitaire Fattouma Bourguiba

研究点 (1)

Loading locations...

相似试验